199730 — BioInfra Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for BioInfra Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	17,290	19,610	30,555	35,427	30,129
Cost of Revenue
Gross Profit	7,804	8,258	12,031	13,972	9,553
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	14,290	15,985	23,093	29,070	28,826
Operating Profit	3,000	3,625	7,463	6,358	1,302
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2,626	3,557	7,099	6,987	1,279
Provision for Income Taxes
Net Income After Taxes	-2,626	4,191	6,234	6,237	2,002
Net Income Before Extraordinary Items
Net Income	-2,626	4,191	6,234	6,237	2,002
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-2,626	4,191	6,234	6,237	2,002
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-547	874	1,294	1,316	426
Dividends per Share